161 related articles for article (PubMed ID: 20091941)
1. Varicella vaccination in pediatric kidney and liver transplantation.
Prelog M; Zimmerhackl LB
Pediatr Transplant; 2010 Feb; 14(1):41-7. PubMed ID: 20091941
[TBL] [Abstract][Full Text] [Related]
2. Varicella zoster virus serostatus before and after kidney transplantation, and vaccination of adult kidney transplant candidates.
Geel AL; Landman TS; Kal JA; van Doomum GJ; Weimar W
Transplant Proc; 2006 Dec; 38(10):3418-9. PubMed ID: 17175291
[TBL] [Abstract][Full Text] [Related]
3. Effectiveness of live varicella vaccine.
Takahashi M
Expert Opin Biol Ther; 2004 Feb; 4(2):199-216. PubMed ID: 14998778
[TBL] [Abstract][Full Text] [Related]
4. Humoral and cellular response after varicella vaccination in VZV IgG seronegative kidney transplant candidates.
Kho MM; Zuijderwijk JM; van der Eijk AA; de Kuiper R; Boer-Verschragen MJ; Weimar W; van Besouw NM
Vaccine; 2017 Jan; 35(1):71-76. PubMed ID: 27899225
[TBL] [Abstract][Full Text] [Related]
5. Attenuated varicella virus vaccine in children with renal transplants.
Zamora I; Simon JM; Da Silva ME; Piqueras AI
Pediatr Nephrol; 1994 Apr; 8(2):190-2. PubMed ID: 8018498
[TBL] [Abstract][Full Text] [Related]
6. α Herpes Virus Infections Among Renal Transplant Recipients.
Abad CL; Razonable RR
Semin Nephrol; 2016 Sep; 36(5):344-350. PubMed ID: 27772619
[TBL] [Abstract][Full Text] [Related]
7. An economic evaluation of varicella vaccine for pediatric liver and kidney transplant recipients.
Kitai IC; King S; Gafni A
Clin Infect Dis; 1993 Sep; 17(3):441-7. PubMed ID: 8218688
[TBL] [Abstract][Full Text] [Related]
8. Safety and immunogenicity of varicella-zoster virus vaccine in pediatric liver and intestine transplant recipients.
Weinberg A; Horslen SP; Kaufman SS; Jesser R; Devoll-Zabrocki A; Fleckten BL; Kochanowicz S; Seipel KR; Levin MJ
Am J Transplant; 2006 Mar; 6(3):565-8. PubMed ID: 16468967
[TBL] [Abstract][Full Text] [Related]
9. Successful vaccination against varicella zoster virus prior to kidney transplantation.
Geel A; Zuidema W; van Gelder T; van Doornum G; Weimar W
Transplant Proc; 2005 Mar; 37(2):952-3. PubMed ID: 15848586
[TBL] [Abstract][Full Text] [Related]
10. Pretransplant varicella vaccination is cost-effective in pediatric renal transplantation.
Olson AD; Shope TC; Flynn JT
Pediatr Transplant; 2001 Feb; 5(1):44-50. PubMed ID: 11260488
[TBL] [Abstract][Full Text] [Related]
11. Immunogenicity of a two-dose regime of varicella vaccine in children with cancers.
Leung TF; Li CK; Hung EC; Chan PK; Mo CW; Wong RP; Chik KW
Eur J Haematol; 2004 May; 72(5):353-7. PubMed ID: 15059071
[TBL] [Abstract][Full Text] [Related]
12. Effectiveness and safety of immunization with live-attenuated and inactivated vaccines for pediatric liver transplantation recipients.
Kawano Y; Suzuki M; Kawada J; Kimura H; Kamei H; Ohnishi Y; Ono Y; Uchida H; Ogura Y; Ito Y
Vaccine; 2015 Mar; 33(12):1440-5. PubMed ID: 25665961
[TBL] [Abstract][Full Text] [Related]
13. Safety of Live Attenuated High-Titer Varicella-Zoster Virus Vaccine in Pediatric Allogeneic Hematopoietic Stem Cell Transplantation Recipients.
Aoki T; Koh K; Kawano Y; Mori M; Arakawa Y; Kato M; Hanada R
Biol Blood Marrow Transplant; 2016 Apr; 22(4):771-775. PubMed ID: 26748161
[TBL] [Abstract][Full Text] [Related]
14. Long-term Seroprotection of Varicella-zoster Immunization in Pediatric Liver Transplant Recipients.
Verolet CM; Pittet LF; Wildhaber BE; McLin VA; Rodriguez M; Grillet S; Siegrist CA; Posfay-Barbe KM
Transplantation; 2019 Nov; 103(11):e355-e364. PubMed ID: 31335765
[TBL] [Abstract][Full Text] [Related]
15. Reduced varicella-zoster-virus (VZV)-specific lymphocytes and IgG antibody avidity in solid organ transplant recipients.
Prelog M; Schönlaub J; Jeller V; Almanzar G; Höfner K; Gruber S; Eiwegger T; Würzner R
Vaccine; 2013 May; 31(20):2420-6. PubMed ID: 23583889
[TBL] [Abstract][Full Text] [Related]
16. Loss of varicella zoster virus antibodies despite detectable cell mediated immunity after vaccination.
Ludwig B; Kraus FB; Allwinn R; Keim S; Doerr HW; Buxbaum S
Infection; 2006 Aug; 34(4):222-6. PubMed ID: 16896582
[TBL] [Abstract][Full Text] [Related]
17. Varicella vaccination elicits a humoral and cellular response in children with rheumatic diseases using immune suppressive treatment.
Groot N; Pileggi G; Sandoval CB; Grein I; Berbers G; Ferriani VPL; Wulffraat N; de Roock S
Vaccine; 2017 May; 35(21):2818-2822. PubMed ID: 28412076
[TBL] [Abstract][Full Text] [Related]
18. Live attenuated varicella vaccine.
Arvin AM; Gershon AA
Annu Rev Microbiol; 1996; 50():59-100. PubMed ID: 8905076
[TBL] [Abstract][Full Text] [Related]
19. Varicella zoster virus: vaccination and implications in children with renal failure.
Fadrowski JJ; Furth SL
Expert Rev Vaccines; 2004 Jun; 3(3):291-8. PubMed ID: 15176945
[TBL] [Abstract][Full Text] [Related]
20. Varicella-zoster-virus vaccination in immunosuppressed children with rheumatic diseases using a pre-vaccination check list.
Speth F; Hinze CH; Andel S; Mertens T; Haas JP
Pediatr Rheumatol Online J; 2018 Mar; 16(1):15. PubMed ID: 29499726
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
